Gene patenting - The Supreme Court finally speaks

New England Journal of Medicine

Volumn 369, Issue 9, 2013, Pages 869-875

  Kesselheim, Aaron S ^a   Cook Deegan, Robert M ^c   Winickoff, David E ^d   Mello, Michelle M ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; COMPLEMENTARY DNA;

ARTICLE; BREAST CANCER; CANCER GENETICS; COURT; DNA SEQUENCE; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SCREENING; HEALTH CARE DELIVERY; HUMAN; HUMAN GENOME; INVESTMENT; JURISPRUDENCE; MEDICAL TECHNOLOGY; PATENT; PATIENT ADVOCACY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 84883130125     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMhle1308199     Document Type: Article

References (39)

1. Association for Molecular Pathology v. Myriad Genetics, 2013 WL 2631062 (June 13, 2013).
2. 35 U.S.C. § 101.
3. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9. (Pubitemid 120031871)
4. Goldgar DE, Fields P, Lewis CM, et al. A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst 1994;86:200-9. (Pubitemid 24042261)
5. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90. (Pubitemid 24325690)
6. Davies K, White M. Breakthrough: the race to find the breast cancer gene. New York: John Wiley, 1996.
7. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92. [Erratum, Nature 1996;379:749.] (Pubitemid 26004412)
8. Couch F, Kamb A, Rommens JM, Simard J, Tavtigian SV, Weber BL. Chromosome 13-linked breast cancer susceptibility gene. U.S. Patent 5,837,492 (Dec. 18, 1995).
9. Idem. Chromosome 13-linked breast cancer susceptibility gene. U.S. Patent 6,033,857 (Dec. 18, 1995).
10. Idem. Chromosome 13-linked breast cancer susceptibility gene. U.S. Patent 6,124,104 (Dec. 18, 1995).
11. Maxmen A. Personalized medicine enters a new era. PBS.org, NOVA Next. March 19, 2013 (http://www.pbs.org/wgbh/nova/next/body/gene-patents-and- personalized-medicine/).
12. Supreme Court upholds Myriad's cDNA patent claims: court also highlights patent eligibility of method claims. Press release of Myriad Genetics, June 13, 2013 (http://investor.myriad.com/releasedetail.cfm?ReleaseID=771232).
13. Cook-Deegan R. Are human genes patentable? Ann Intern Med 2013 June 11 (Epub ahead of print).
14. Kesselheim AS, Mello MM. Gene patenting - is the pendulum swinging back? N Engl J Med 2010;362:1855-8.
15. Walsh T, Lee MK, Casadei S, et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A 2010;107:12629-33.
16. Cho MK, Illangasekare S, Weaver MA, Leonard DG, Merz JF. Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003;5:3-8. (Pubitemid 36192993)
17. Merz JF, Kriss AG, Leonard DG, Cho MK. Diagnostic testing fails the test. Nature 2002;415:577-9. (Pubitemid 34136365)
18. Williams HL. Intellectual property rights and innovation: evidence from the human genome. J Polit Econ 2013;121:1-27.
19. Diamond v. Chakrabarty, 447 U.S. 303 (1980).
20. Association for Molecular Pathology v. U.S. Patent & Trademark Office, 702 F. Supp. 2d 181 (S.D.N.Y. 2010).
21. Association for Molecular Pathology v. U.S. Patent & Trademark Office, 653 F.3d 1329 (Fed.Cir. 2011).
22. Cook-Deegan R. Patent law: law and science collide over human gene patents. Science 2012;338:745-7.
23. Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S., 132 S. Ct. 1289 (2012).
24. Association for Molecular Pathology v. U.S. Patent & Trademark Office, 689 F.3d 1303 (Fed.Cir. 2012).
25. Funk Bros. Seed Co. v. Kalo Inoculant Co., 333 U.S. 127 (1948).
26. Bilski v. Kappos, 561 U.S., 130 S. Ct. 3218 (2010).
27. Kesselheim AS, Karlawish J. Biomarkers unbound - the Supreme Court's ruling on diagnostic-test patents. N Engl J Med 2012;366:2338-40.
28. Park SS. VICTORY! The Supreme Court decides: our genes belong to us, not companies. Blog of Rights. June 13, 2013 (http://www.aclu.org/blog/womens- rights-free-speech-technology-and-liberty/victory-supreme-court-decides-our- genes-belong/).
29. Langreth R, Pettypiece S. Myriad gene patent ruling triggers race for cancer tests. Bloomberg Law. June 14, 2013 (http://about.bloomberglaw.com/legal- news/myriad-gene-patent-ruling-triggers-race-for-cancer-tests/).
30. Perkel JM. Gene patents decision: everybody wins. The Scientist. June 18, 2013 (http://www.the-scientist.com/?articles.view/articleNo/36076/title/Gene- Patents-Decision-Everybody-Wins/).
31. Decker S. Myriad Genetics sues Ambry to thwart rival cancer test. July 9, 2013 (http://www.bloomberg.com/news/2013-07-09/myriad-genetics-sues-ambry-to- thwart-rival-cancer-test.html).
32. Easton DF, Deffenbaugh AM, Pruss D, et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 2007;81:873-83. (Pubitemid 47580242)
33. Sharing Clinical Reports Project. Free the data!! (http:// sharingclinicalreports.org/).
34. Kolata G. DNA project aims to make public a company's data on cancer genes. New York Times. April 12, 2013:A14.
35. Rai AK, Cook-Deegan R. Moving beyond "isolated" gene patents. Science (in press).
36. Graff GD, Phillips D, Lei Z, Oh S, Nottenburg C, Pardey PG. Not quite a myriad of gene patents. Nat Biotechnol 2013;31:404-10.
37. Kling J. Where the future went: in response to market trends and patenting laws, genomics companies are adapting their strategies. EMBO Rep2005;6:1012-4.
38. Human gene patent report. 2012 (http://hgpr.org/finalHGPR.pdf).
39. United Nations Educational, Scientific and Cultural Organization. Universal Declaration on the Human Genome and Human Rights, Art. 1, 4. (http://portal.unesco.org/en/ev.php-URL-ID=13177&URL-DO=DO-TOPIC&URL- SECTION=201.html).